BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29886204)

  • 21. Influence of comorbid anxiety symptoms on cognitive deficits in patients with major depressive disorder.
    Liu J; Dong Q; Lu X; Sun J; Zhang L; Wang M; Liu B; Ju Y; Wan P; Guo H; Zhao F; Zhang X; Zhang Y; Li L
    J Affect Disord; 2020 Jan; 260():91-96. PubMed ID: 31493645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive functioning and lifetime major depressive disorder in UK Biobank.
    de Nooij L; Harris MA; Adams MJ; Clarke TK; Shen X; Cox SR; McIntosh AM; Whalley HC
    Eur Psychiatry; 2020 Feb; 63(1):e28. PubMed ID: 32189608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics associated with the discrepancy between subjective and objective cognitive impairment in depression.
    Petersen JZ; Porter RJ; Miskowiak KW
    J Affect Disord; 2019 Mar; 246():763-774. PubMed ID: 30623822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of cognitive deficits with mental and physical Quality of Life in Major Depressive Disorder.
    Knight MJ; Lyrtzis E; Baune BT
    Compr Psychiatry; 2020 Feb; 97():152147. PubMed ID: 31838296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample.
    Ohaeri JU; Awadalla AW
    Med Sci Monit; 2012 Mar; 18(3):CR160-73. PubMed ID: 22367127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive complaints and predictors of perceived cognitive dysfunction in adults with major depressive disorder: Findings from the Cognitive Dysfunction in Asians with Depression (CogDAD) study.
    Srisurapanont M; Mok YM; Yang YK; Chan HN; Della CD; Zainal NZ; Jambunathan S; Amir N; Kalita P
    J Affect Disord; 2018 May; 232():237-242. PubMed ID: 29499506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study.
    Almeida SS; Christensen MC; Simonsen K; Adair M
    J Psychopharmacol; 2023 Mar; 37(3):279-288. PubMed ID: 36377523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrepancy between objective and subjective cognition in adults with major depressive disorder.
    Srisurapanont M; Suttajit S; Eurviriyanukul K; Varnado P
    Sci Rep; 2017 Jun; 7(1):3901. PubMed ID: 28634383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status.
    Fourrier C; Sampson E; Hori H; Schubert KO; Clark S; Mills NT; Baune BT
    Brain Behav Immun; 2020 Aug; 88():242-251. PubMed ID: 32526448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing cognitive styles in social anxiety and major depressive disorders: An examination of rumination, worry, and reappraisal.
    Arditte Hall KA; Quinn ME; Vanderlind WM; Joormann J
    Br J Clin Psychol; 2019 Jun; 58(2):231-244. PubMed ID: 30484868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biased neurocognitive self-perception in depressive and in healthy persons.
    Schwert C; Stohrer M; Aschenbrenner S; Weisbrod M; Schröder A
    J Affect Disord; 2018 May; 232():96-102. PubMed ID: 29481997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of automatical thoughts among generalized anxiety disorder, major depressive disorder and generalized social phobia patients.
    Gül AI; Simsek G; Karaaslan Ö; Inanir S
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2916-21. PubMed ID: 26241548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change.
    McIntyre RS; Subramaniapillai M; Park C; Zuckerman H; Cao B; Lee Y; Iacobucci M; Nasri F; Fus D; Bowie CR; Tran T; Rosenblat JD; Mansur RB
    Front Psychiatry; 2020; 11():546. PubMed ID: 32670103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression.
    Zhang W; Zhu N; Lai J; Liu J; Ng CH; Chen J; Qian C; Du Y; Hu C; Chen J; Hu J; Wang Z; Zhou H; Xu Y; Fang Y; Shi C; Hu S
    Neuropsychiatr Dis Treat; 2020; 16():2419-2428. PubMed ID: 33116541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between self-reported cognitive difficulties, objective neuropsychological test performance and psychological distress in chronic pain.
    Baker KS; Gibson SJ; Georgiou-Karistianis N; Giummarra MJ
    Eur J Pain; 2018 Mar; 22(3):601-613. PubMed ID: 29160603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between work functioning and self-reported cognitive complaints in patients with major depressive disorder treated with desvenlafaxine.
    Alonso-Prieto E; Rubino C; Lucey M; Evans VC; Tam EM; Woo C; Iverson GL; Chakrabarty T; Yatham LN; Lam RW
    Psychiatry Res; 2019 Feb; 272():144-148. PubMed ID: 30583256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.
    Chakrabarty T; Harkness KL; McInerney SJ; Quilty LC; Milev RV; Kennedy SH; Frey BN; MacQueen GM; Müller DJ; Rotzinger S; Uher R; Lam RW
    Psychol Med; 2020 Nov; 50(15):2536-2547. PubMed ID: 31583989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Sampson E; Mills NT; Hori H; Schwarte K; Hohoff C; Schubert O; Clark SR; Fourrier C; Baune BT
    J Clin Psychiatry; 2023 Oct; 84(6):. PubMed ID: 37796652
    [No Abstract]   [Full Text] [Related]  

  • 39. Using self-reported vocational functioning measures to identify employed patients with impaired functional capacity in major depressive disorder.
    Murthy NV; Xu R; Zhong W; Harvey PD
    J Affect Disord; 2020 Jan; 260():550-556. PubMed ID: 31539692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
    Yoo I; Woo JM; Lee SH; Fava M; Mischoulon D; Papakostas GI; Kim EJ; Chung S; Ha JH; Jeon HJ
    J Affect Disord; 2015 Oct; 185():24-30. PubMed ID: 26142691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.